We don't cater to customers in UAE, we only ship internationally.

Sipmax International
  • BORTECAD 2.5 Injection
  • BORTECAD 2.5 Injection

BORTECAD 2.5 Injection

BORTECAD 2.5 Injection BORTECAD 2.5 contains Bortezomib, a targeted proteasome inhibitor that reversibly blocks the chymotrypsin-like activity of the 26S proteasome. By inhibiting protein degradation within the cell, it disrupts homeostatic signaling cascades and induces apoptosis in cancer cells. It is indicated for the treatment of patients with multiple myeloma and mantle cell lymphoma.

Read more
WhatsApp Telegram Email
Brand BORTECAD
Storage Temperature Store below 25°C in a dry place, protected from light (Do not freeze)
Prescription Needed Yes
Composition Bortezomib
Strength 2.5 mg
Form Lyophilized Powder for Solution for Injection
Pack Size 1 Vial
Packaging Single-dose glass vial
Country of Origin Made In India
Manufacturer Cadila Pharmaceuticals Ltd. (Oncocare Division)

BORTECAD 2.5 Injection

BORTECAD 2.5 Injection BORTECAD 2.5 contains Bortezomib, a targeted proteasome inhibitor that reversibly blocks the chymotrypsin-like activity of the 26S proteasome. By inhibiting protein degradation within the cell, it disrupts homeostatic signaling cascades and induces apoptosis in cancer cells. It is indicated for the treatment of patients with multiple myeloma and mantle cell lymphoma.

Related Products